Last reviewed · How we verify
Ialuset®
Ialuset is a topical wound healing agent that promotes tissue repair and epithelialization through enhanced cellular proliferation and collagen deposition.
Ialuset is a topical wound healing agent that promotes tissue repair and epithelialization through enhanced cellular proliferation and collagen deposition. Used for Chronic and acute wounds, Burn wounds, Surgical wounds.
At a glance
| Generic name | Ialuset® |
|---|---|
| Sponsor | Centre Francois Baclesse |
| Drug class | Wound healing agent |
| Modality | Small molecule |
| Therapeutic area | Dermatology / Wound Care |
| Phase | Phase 3 |
Mechanism of action
Ialuset contains hyaluronic acid and amino acids that stimulate fibroblast activity and promote the formation of granulation tissue. The formulation enhances the natural wound healing process by providing a moist environment and delivering growth-promoting substrates to facilitate faster re-epithelialization and tissue regeneration.
Approved indications
- Chronic and acute wounds
- Burn wounds
- Surgical wounds
- Ulcers
Common side effects
- Local irritation
- Allergic contact dermatitis
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ialuset® CI brief — competitive landscape report
- Ialuset® updates RSS · CI watch RSS
- Centre Francois Baclesse portfolio CI